Posted on

Medtronic Medical Devices – Most Active Medical Device Companies

TMedtronic Medical Deviceshis post on Medtronic medical devices is a continuation of a series of posts that examine a group of companies that are considered to be among the global leaders in the medical device industry. Inclusion to this group is not based on any quantitative measure, such as annual sales in revenue or units, but on a company’s overall medical device sector activity – things that include the number of business units in the company’s device supply stream, or the number of product codes per device application segment. In other words, each company’s overall global footprint. 


Much of the data for this post came from Greystone’s fully searchable version of the FDA Establishment Registration and Device Listing database (EstReg DB). The database, which is updated annually, is the most comprehensive listing of medical device suppliers and service providers in the world. We’ve created a fully searchable version of the database – TotalVision©. More information on TotalVision© can be found at the end of this post.


Medtronic Medical Devices – Geographic Reach

Medtronic, directly or through its subsidiaries/affiliate companies operates in the medical device segment across seventeen distinct locations in the USA. The Company also operates from eight countries in Europe and Asia. In total, there are forty-two Medtronic subsidiaries and affiliates listed in the EstReg DB. The complete list of Medtronic subsidiary and affiliate companies are included in our free Medtronic Summary report that is available by request. Please refer to the request form below this post.


Medtronic Medical Devices – Device Applications

Medtronic, its subsidiaries and affiliations are credited with over 400 product codes listed in the FDA Establishment Registration and Device Listing database for 2020. These products represent sixteen different device applications. The most prominent applications are Cardiovascular and Surgery, followed by Neurology. The most active business units are Medtronic Sofamor Danek USA, Inc., Warsaw Orthopedic, Inc., Medtronic Xomed, Inc., and Medtronic Perfusion Systems, Medtronic Mexico S. de R.L. de C.V. Medtronic also has a prominent presence in Puerto Rico that includes three separate subsidiaries: (1) Medtronic Puerto Operations Co., Humacao; (2) Medtronic Puerto Rico Operations Co., Juncos; and (3) Medtronic Puerto Rico Operations CO., Villalba.


Device Operations

Medtronic has four operating and reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services: the Cardiac and Vascular Group, the Minimally Invasive Therapies Group, the Restorative Therapies Group, and the Diabetes Group. The major medical device product sectors include the following:

Cardiovascular products include implantable devices, leads and delivery systems, products for the treatment of atrial fibrillation (AF), products designed to reduce surgical site infections, information systems for the management of patients with Cardiac Rhythm & Heart Failure devices, ventricular assist systems, and an integrated health solutions business. The Company’s Coronary & Structural Heart division includes therapies to treat coronary artery disease and heart valve disorders. Our products include coronary stents and related delivery systems, including a broad line of balloon angioplasty catheters, guide catheters, guide wires, diagnostic catheters, and accessories, as well as products for the repair and replacement of heart valves, perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, and surgical ablation products. 

The Surgical Innovations division develops, manufactures, and markets advanced and general surgical products including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products and therapies to treat diseases and conditions that are typically, but not exclusively, addressed by surgeons. The Respiratory, Gastrointestinal, & Renal division develops, manufactures, and markets products in the emerging fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, respiratory interventions including airway management and ventilation therapies, and for the treatment of renal disease.

The Brain Therapies division develops, manufactures, and markets an integrated portfolio of devices and therapies for the treatment of neurological disorders and diseases, as well as surgical technologies designed to improve the precision and workflow of neuro procedures. Principal products and services offered include:
•Neurovascular products to treat diseases of the vasculature in and around the brain. This includes coils, neurovascular stent retrievers, and flow diversion products, as well as access and delivery products to support procedures. 
•Brain modulation products, including those for the treatment of the disabling symptoms of Parkinson’s disease, essential tremor, refractory epilepsy, severe, and treatment-resistant obsessive compulsive disorder.


M&A Activity

Medtronic M&A activity has been light over the past two years. The one notable transaction was the Company’s Restorative Therapies Group acquisition of Mazor Robotics (Mazor), a pioneer in the field of robotic guidance systems. The acquisition of Mazor strengthened the Company’s position as a global leader in enabling technologies for spine surgery. The Company offers a fully-integrated procedural solution for surgical planning, execution, and confirmation by combining the Company’s spine implants, navigation, and intra-operative imaging technology with Mazor’s robotic-assisted surgery systems. Total consideration for the transaction, net of cash acquired, was $1.6 billion, consisting of $1.3 billion of cash and $246 million of a previously-held equity investment in Mazor.


As mentioned above, much of the data for this post came from Greystone’s fully searchable version of the FDA Establishment Registration and Device Listing database. The database, which requires listed entities to update their data annually, is the most comprehensive listing of medical device suppliers and service providers in the world. We’ve built a user friendly interface that allows industry professionals to parse, collate and aggregate medical device information across geographic locations (cities, states, provinces, countries), device applications (e.g., cardiovascular, ENT, orthopedics, surgery, etc.), product codes, suppliers, and establishment services (e.g., contract manufacturing, re-packagers, specifiers, etc.). This information tool – TotalVision© – allows users to search the 41,000 rows in the database across thirteen tables and eight searchable dimensions and return precise data sets and information by filtering the data, in a matter of seconds. For more information on TotalVision©, please reach out to us by using the form below.


TotalVision© Information Request